Navigation Links
Dehaier Medical Announces March Investor Presentations
Date:3/1/2011

BEIJING, March 1, 2011 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (Nasdaq: DHRM) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that management will present at the following investment community conferences in March:

(Logo: http://photos.prnewswire.com/prnh/20100422/CNTH001LOGO)

  • Rodman & Renshaw Annual China Investment Conference in Shanghai, China on March 8, 2011 at 2:25 p.m. Beijing time.
  • ROTH 23rd Annual OC Growth Stock Conference in Laguna Niguel, Calif. on March 15, 2011 at 2:00 p.m. Pacific Standard Time.

  • Investors attending the Rodman & Renshaw or ROTH conference are invited to visit management's formal presentations at the above times and venues. Attending investors are also encouraged to schedule one-on-one meeting with management at these conferences by contacting their sales person at the appropriate conference, or by contacting Lee Roth at (212) 481-2050 or dehaier@tpg-ir.com.

    About Dehaier Medical Systems Ltd.Dehaier Medical Systems is an emerging leader in the development, assembly, marketing and sale of medical products in China, including respiratory and oxygen homecare medical products. The company develops and assembles its own branded products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices and respiratory and oxygen homecare products from IMD (Italy), Welch Allyn (USA) and HEYER (Germany), Timesco (UK), ResMed (Australia), and JMS (Japan). Dehaier's technology is based on two patents, six pending patents, and proprietary technology. More information may be found at http://www.chinadhr.com.

    Forward-looking StatementsThis news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.Contact UsIn the US:The Piacente Group, Inc. Investor Relations Brandi Floberg or Lee Roth(212) 481-2050dehaier@tpg-ir.comIn China:The Piacente Group, Inc. Investor RelationsWendy Sun+86 10-6590-7991dehaier@tpg-ir.comDehaier Medical Systems LimitedRita LiuCFO+86 10-8844-5026liuz@dehaier.com.cnAnan LiuInvestor Relations Manager+86 10-5166-0080 ext 169liuanan@dehaier.com.cn
    '/>"/>

    SOURCE Dehaier Medical Systems Ltd.
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Dehaier Medical Systems Announces Closing of Initial Public Offering on NASDAQ
    2. Dehaier Medical Systems Announces First Quarter Net Income Up 54%
    3. Dehaier Medical Systems Announces New Exclusive China Distribution Agreement with Welch Allyn, Further Broadening Companys Product Lines
    4. Dehaier Medical Systems Chief Executive Officer To Ring NASDAQ Stock Market Closing Bell
    5. Dehaier Medical Systems to Present to Investors at Global Hunter Securities 2010 China Investor Conference in San Francisco
    6. Dehaier Medical Systems Acquires Emergency Ventilator Series to Extend Product Line
    7. Dehaier Medical Systems Q2 Revenue Up 46% to $4.83 Million; Net Income Up 59% to 1.14 Million; EPS 0.27
    8. Dehaier Medical Systems Announces Engagement of RedChip Companies to Lead Public and Investor Relations
    9. Dehaier Medical Shows New Products at 2010 China International Medical Equipment Fair
    10. Dehaier Medical Wins $2 Million Distribution Bid for Rural Healthcare Construction Project
    11. Dehaier Medical to Participate in MEDICA International Trade Fair
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/24/2016)... , June 24, 2016  Collagen Matrix, ... design, development and manufacturing of collagen and mineral ... announced today that Bill Messer has ... Marketing to further leverage the growing portfolio of ... devices. Bill joins the Collagen Matrix ...
    (Date:6/24/2016)... -- The Academy of Managed Care Pharmacy (AMCP) today ... allow biopharmaceutical companies to more easily share health care ... coverage decisions, a move that addresses the growing need ... The recommendations address restrictions in the sharing of product ... a prohibition that hinders decision makers from accessing HCEI ...
    (Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
    Breaking Medicine Technology:
    (Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
    (Date:6/25/2016)... ... , ... Austin residents seeking Mohs surgery services, can now turn to Dr. ... Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include ... in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn ...
    (Date:6/25/2016)... CA (PRWEB) , ... June 25, 2016 , ... As ... with Magna Cum Laude and his M.D from the David Geffen School of Medicine ... and returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive ...
    (Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
    (Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
    Breaking Medicine News(10 mins):